Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

[1]  N. Patronas,et al.  Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  A. Vénisse,et al.  The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  J. Carrasquillo,et al.  Use of 6‐[18F]‐fluorodopamine positron emission tomography (PET) as first‐line investigation for the diagnosis and localization of non‐metastatic and metastatic phaeochromocytoma (PHEO) , 2009, Clinical endocrinology.

[4]  P. Choyke,et al.  Noninvasive monitoring of a murine model of metastatic pheochromocytoma: A comparison of contrast‐enhanced microCT and nonenhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[5]  J. Romijn,et al.  Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[6]  J. Carrasquillo,et al.  The Effects of Carbidopa on Uptake of 6-18F-Fluoro-l-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma , 2007, Journal of Nuclear Medicine.

[7]  S. Tayebati,et al.  Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells. , 2007, American journal of physiology. Renal physiology.

[8]  E. Croteau,et al.  A Small Animal Positron Emission Tomography Study of the Effect of Chemotherapy and Hormonal Therapy on the Uptake of 2-Deoxy-2-[F-18]fluoro-d-glucose in Murine Models of Breast Cancer , 2007, Molecular Imaging and Biology.

[9]  K. Garber.  Realistic rodents? Debate grows over new mouse models of cancer. , 2006, Journal of the National Cancer Institute.

[10]  R. Worrell,et al.  Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. , 2005, European journal of endocrinology.

[11]  J. Lipski,et al.  Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma , 2005, Cell and Tissue Research.

[12]  D. Goldstein,et al.  Functional imaging of endocrine tumors: role of positron emission tomography. , 2004, Endocrine reviews.

[13]  Jeih-San Liow,et al.  Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Jamey P Weichert,et al.  Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. , 2004, The Journal of surgical research.

[15]  K. Pacak,et al.  Current approaches and new advances in endocrine hypertension , 2002, Trends in endocrinology and metabolism.

[16]  J. Seidel,et al.  Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[17]  E. Nitzsche,et al.  Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. , 2001, Radiology.

[18]  Graeme Eisenhofer,et al.  6-[18F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma , 2001, Hypertension.

[19]  G. Eisenhofer.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[20]  A. Tischler,et al.  Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice , 2000, Cell and Tissue Research.

[21]  J. Lipski,et al.  Localization of the Noradrenaline Transporter in Rat Adrenal Medulla and PC12 Cells , 1999, Journal of neurochemistry.

[22]  S. Gilman,et al.  Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography , 1999, Annals of neurology.

[23]  McDonald,et al.  Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma , 1999, Histopathology.

[24]  D. Hauri,et al.  Pheochromocytomas: can malignant potential be predicted? , 1999, Urology.

[25]  J. Kuhlman,et al.  CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques. , 1997, Radiology.

[26]  D. Goldstein,et al.  6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function — studies in normal humans , 1997, Clinical Autonomic Research.

[27]  S. Gilman,et al.  Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging , 1996, Annals of neurology.

[28]  R. Counsell,et al.  Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. , 1996, Journal of pharmaceutical sciences.

[29]  T. Bonner,et al.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Keyes.  SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  R. Edwards,et al.  Differential expression of two vesicular monoamine transporters , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  J. Playfer,et al.  Measuring L-dopa in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with L-dopa and a dopa decarboxylase inhibitor. , 1993, Clinical chemistry.

[33]  M. Esler,et al.  Neuronal Reuptake of Norepinephrine and Production of Dihydroxyphenyiglycol by Cardiac Sympathetic Nerves in the Anesthetized Dog , 1991, Circulation.

[34]  D. Goldstein,et al.  Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. , 1991, Journal of hypertension.

[35]  J. Hancock,et al.  Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C) , 1991, International journal of cancer.

[36]  F. Izumi,et al.  Inhibition of 22Na influx by tricyclic and tetracyclic antidepressants and binding of [3H]imipramine in bovine adrenal medullary cells. , 1987, Journal of Pharmacology and Experimental Therapeutics.

[37]  D. Murphy,et al.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. , 1986, Clinical chemistry.

[38]  H. Woodard,et al.  Letter: Expression of tissue isotope distribution. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  J. Carrasquillo,et al.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. , 2009, The Journal of clinical endocrinology and metabolism.

[40]  D. Adler,et al.  Neuroendocrine Tumors: Review and Clinical Update , 2007 .

[41]  M. Schäfer,et al.  Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat , 2007, Journal of Molecular Neuroscience.

[42]  D. Goldstein,et al.  Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. , 1989, The Journal of pharmacology and experimental therapeutics.